Hypomethylation of the LncRNA H19 promoter accelerates osteogenic differentiation of vascular smooth muscle cells by activating the Erk1/2 pathways
Objective Vascular calcification is a common chronic kidney disease complication. This study aimed to investigate the function of long non-coding RNA (LncRNA) H19 in vascular calcification to explore new therapeutic strategies. Methods We induced osteogenic differentiation and calcification of vascu...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-03-01
|
| Series: | Journal of International Medical Research |
| Online Access: | https://doi.org/10.1177/03000605241234567 |
| _version_ | 1797243542501851136 |
|---|---|
| author | Taoxia Wang Meijuan Cheng Jingjing Jin Yaling Bai Dongxue Zhang Shenglei Zhang Jinsheng Xu |
| author_facet | Taoxia Wang Meijuan Cheng Jingjing Jin Yaling Bai Dongxue Zhang Shenglei Zhang Jinsheng Xu |
| author_sort | Taoxia Wang |
| collection | DOAJ |
| description | Objective Vascular calcification is a common chronic kidney disease complication. This study aimed to investigate the function of long non-coding RNA (LncRNA) H19 in vascular calcification to explore new therapeutic strategies. Methods We induced osteogenic differentiation and calcification of vascular smooth muscle cells (VSMCs) using β-glycerophosphate. Then, we detected the LncRNA H19 promoter methylation status and Erk1/2 pathways using methylation-specific polymerase chain reaction and western blotting, respectively. Results Compared with the control group, high phosphorus levels induced VSMC calcification, accompanied by increases in LncRNA H19 and the osteogenic marker Runx2 and reduction of the contractile phenotype marker SM22a. LncRNA H19 knockdown inhibited osteogenic differentiation and calcification of VSMCs. However, the suppressed role of VSMC calcification caused by shRNA H19 was partially reversed by simultaneous activation of the Erk1/2 pathways. Mechanically, we found that the methylation rate of CpG islands in the LncRNA H19 promoter region was significantly lower in the high-phosphorus group, and the hypomethylation state elevated LncRNA H19 levels, which in turn regulated phosphorylated Erk1/2 expression. Conclusions LncRNA H19 promoted osteogenic differentiation and calcification of VSMCs by regulating the Erk1/2 pathways. Additionally, hypomethylation of LncRNA H19 promoter CpG islands upregulated LncRNA H19 levels and subsequently activated Erk1/2 phosphorylation. |
| first_indexed | 2024-04-24T18:56:46Z |
| format | Article |
| id | doaj.art-e14e51424c4b46d9ba550465b73d5984 |
| institution | Directory Open Access Journal |
| issn | 1473-2300 |
| language | English |
| last_indexed | 2024-04-24T18:56:46Z |
| publishDate | 2024-03-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Journal of International Medical Research |
| spelling | doaj.art-e14e51424c4b46d9ba550465b73d59842024-03-26T17:03:31ZengSAGE PublishingJournal of International Medical Research1473-23002024-03-015210.1177/03000605241234567Hypomethylation of the LncRNA H19 promoter accelerates osteogenic differentiation of vascular smooth muscle cells by activating the Erk1/2 pathwaysTaoxia WangMeijuan ChengJingjing JinYaling BaiDongxue ZhangShenglei ZhangJinsheng XuObjective Vascular calcification is a common chronic kidney disease complication. This study aimed to investigate the function of long non-coding RNA (LncRNA) H19 in vascular calcification to explore new therapeutic strategies. Methods We induced osteogenic differentiation and calcification of vascular smooth muscle cells (VSMCs) using β-glycerophosphate. Then, we detected the LncRNA H19 promoter methylation status and Erk1/2 pathways using methylation-specific polymerase chain reaction and western blotting, respectively. Results Compared with the control group, high phosphorus levels induced VSMC calcification, accompanied by increases in LncRNA H19 and the osteogenic marker Runx2 and reduction of the contractile phenotype marker SM22a. LncRNA H19 knockdown inhibited osteogenic differentiation and calcification of VSMCs. However, the suppressed role of VSMC calcification caused by shRNA H19 was partially reversed by simultaneous activation of the Erk1/2 pathways. Mechanically, we found that the methylation rate of CpG islands in the LncRNA H19 promoter region was significantly lower in the high-phosphorus group, and the hypomethylation state elevated LncRNA H19 levels, which in turn regulated phosphorylated Erk1/2 expression. Conclusions LncRNA H19 promoted osteogenic differentiation and calcification of VSMCs by regulating the Erk1/2 pathways. Additionally, hypomethylation of LncRNA H19 promoter CpG islands upregulated LncRNA H19 levels and subsequently activated Erk1/2 phosphorylation.https://doi.org/10.1177/03000605241234567 |
| spellingShingle | Taoxia Wang Meijuan Cheng Jingjing Jin Yaling Bai Dongxue Zhang Shenglei Zhang Jinsheng Xu Hypomethylation of the LncRNA H19 promoter accelerates osteogenic differentiation of vascular smooth muscle cells by activating the Erk1/2 pathways Journal of International Medical Research |
| title | Hypomethylation of the LncRNA H19 promoter accelerates osteogenic differentiation of vascular smooth muscle cells by activating the Erk1/2 pathways |
| title_full | Hypomethylation of the LncRNA H19 promoter accelerates osteogenic differentiation of vascular smooth muscle cells by activating the Erk1/2 pathways |
| title_fullStr | Hypomethylation of the LncRNA H19 promoter accelerates osteogenic differentiation of vascular smooth muscle cells by activating the Erk1/2 pathways |
| title_full_unstemmed | Hypomethylation of the LncRNA H19 promoter accelerates osteogenic differentiation of vascular smooth muscle cells by activating the Erk1/2 pathways |
| title_short | Hypomethylation of the LncRNA H19 promoter accelerates osteogenic differentiation of vascular smooth muscle cells by activating the Erk1/2 pathways |
| title_sort | hypomethylation of the lncrna h19 promoter accelerates osteogenic differentiation of vascular smooth muscle cells by activating the erk1 2 pathways |
| url | https://doi.org/10.1177/03000605241234567 |
| work_keys_str_mv | AT taoxiawang hypomethylationofthelncrnah19promoteracceleratesosteogenicdifferentiationofvascularsmoothmusclecellsbyactivatingtheerk12pathways AT meijuancheng hypomethylationofthelncrnah19promoteracceleratesosteogenicdifferentiationofvascularsmoothmusclecellsbyactivatingtheerk12pathways AT jingjingjin hypomethylationofthelncrnah19promoteracceleratesosteogenicdifferentiationofvascularsmoothmusclecellsbyactivatingtheerk12pathways AT yalingbai hypomethylationofthelncrnah19promoteracceleratesosteogenicdifferentiationofvascularsmoothmusclecellsbyactivatingtheerk12pathways AT dongxuezhang hypomethylationofthelncrnah19promoteracceleratesosteogenicdifferentiationofvascularsmoothmusclecellsbyactivatingtheerk12pathways AT shengleizhang hypomethylationofthelncrnah19promoteracceleratesosteogenicdifferentiationofvascularsmoothmusclecellsbyactivatingtheerk12pathways AT jinshengxu hypomethylationofthelncrnah19promoteracceleratesosteogenicdifferentiationofvascularsmoothmusclecellsbyactivatingtheerk12pathways |